Sponsor:
Northwell Health
Code:
NCT00902447
Conditions
Human Blood Cell Disorders
Lymphoid, Myeloid and Erythroid Proliferative Disease
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Accepted
Brief summary:
Conditions
Human Blood Cell Disorders
Lymphoid, Myeloid and Erythroid Proliferative Disease
Study ID
NCT00902447
Start date
Apr, 2009
Status verified date
Nov, 2026
Completion date
Jan, 2035
Anticipated
Primary completion date
Jan, 2030
Anticipated
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Accepted
Enrollment
10000 participants
Anticipated
Arms
Human Blood Cell Disorders
Primary outcome measure
Central contacts
Yasmine Kieso, MSCR
ykieso@northwell.eduLocations
The Feinstein Institute for Medical Research
Recruiting
Manhasset, New York, United States, 11030
Contacts
Yasmine Kieso, MSCR
ykieso@northwell.eduPrincipal Investigator:
Nicholas Chiorazzi, M.D.
Sponsor
Northwell Health
Last update posted
Nov 20, 2026
Last verified
Nov, 2026
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-11-21. This information was provided to ClinicalTrials.gov by Northwell Health on 2026-11-20. Recruitment status is synced daily from ClinicalTrials.gov and may not reflect the sponsor's current status. Confirm during your call.